Zealand Pharma A/S

Public limited companyCVR 20045078SøborgActive

Zealand Pharma A/S is a public limited company, based in Søborg, active in research and experimental development on natural sciences and engineering, founded in 1997. After a loss in 2024, the company made a profit of DKK 6.5bn in 2025. Measured by gross profit, it ranks no. 2 of 421 companies in the industry in the database. With 569 employees, the company is about 114 times larger than the industry median.

PDF report Compare

Key figures · financial year 2025

RevenueDKK 9.2bn+14,598.9% vs. 2024

Net profitDKK 6.5bn+698.3% vs. 2024

EquityDKK 14.8bn+72.1% vs. 2024

Employees569latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

Gross profit rose 16,709% (2024 → 2025), to DKK 9.2bn.
Revenue rose 14,599% (2024 → 2025), to DKK 9.2bn.
Net profit went from a loss of DKK 1.1bn to a profit of DKK 6.5bn (2024 → 2025).
Equity rose 72% (2024 → 2025), to DKK 14.8bn.

Employees

131 more employees than a year earlier: 569 (07/2026) against 438 (07/2025).

Management and owners, last 24 months

New in management: Iris Katharina Löw-Friedrich (board member, 26/03/2026) and Camilla Sylvest (board member, 26/05/2026).
Stepped down: Jeffrey Berkowitz (board member, 26/03/2026) and Bernadette Mary Connaughton (board member, 26/03/2026).
New owners registered: Zealand Pharma A/S (21/08/2026).

Registrations, last 24 months

10/09/2026: Share capital changed from 71,578,758 DKK to 71,610,005 DKK
08/06/2026: Share capital changed from 71,525,575 DKK to 71,578,758 DKK
19/03/2026: Share capital changed from 71,515,045 DKK to 71,525,575 DKK
11/12/2025: Share capital changed from 71,364,728 DKK to 71,515,045 DKK
11/09/2025: Share capital changed from 71,343,804 DKK to 71,364,728 DKK
06/06/2025: Share capital changed from 71,051,296 DKK to 71,343,804 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2015–2025 · amounts in DKK thousand

Equity and net profit

EquityNet profit

Financial figures for Zealand Pharma A/S
	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	Change
Revenue	187,677	234,778	139,775	37,977	41,333	353,314	292,567	103,986	342,788	62,691	9,214,860	+14,598.9%
Gross profit	165,410	–	–	–	–	262,749	173,753	103,986	323,614	54,817	9,214,044	+16,708.7%
Operating profit (EBIT)	−81,327	−115,646	−246,384	652,390	−587,942	−792,361	−1,052,370	−837,153	−572,238	−1,272,207	6,959,436	+647%
Profit before tax	−119,832	−159,410	−277,771	625,056	−576,677	−839,653	−1,026,940	−972,041	−708,865	−1,083,445	7,001,065	+746.2%
Net profit	−113,957	−153,910	−272,271	581,282	−571,541	−846,729	−1,018,149	−1,202,135	−703,739	−1,078,828	6,455,008	+698.3%
Total assets	634,688	694,626	737,238	1,229,797	1,599,514	1,761,949	2,067,629	1,539,806	1,979,993	9,505,600	15,948,798	+67.8%
Equity	252,231	278,194	528,468	1,116,281	1,242,673	1,229,311	927,803	815,911	1,592,839	8,616,742	14,830,613	+72.1%
Liabilities	382,457	416,432	208,770	113,516	356,841	532,638	1,139,826	723,895	387,154	888,858	1,118,185	+25.8%
Cash and cash equivalents	440,199	323,330	588,718	860,635	1,081,060	960,221	1,129,103	1,069,234	449,311	480,303	4,576,541	+852.8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

Compare with the industry (431 companies)

Gross profitMedian, the industry (431 companies)

Annual reports

11 financial years

Annual reports for Zealand Pharma A/S
Financial year	Period	Published	Figures for	Documents
2025	01/01/2025 – 31/12/2025	27/03/2026	The company	PDF not statedXBRL
2024	01/01/2024 – 31/12/2024	04/04/2025	The company	PDF not statedXBRL
2023	01/01/2023 – 31/12/2023	21/03/2024	The company	PDF not statedXBRL
2022	01/01/2022 – 31/12/2022	03/04/2023	The company	PDF not statedXBRL
2021	01/01/2021 – 31/12/2021	04/05/2022	The company	PDF not statedXBRL
2020	01/01/2020 – 31/12/2020	21/04/2021	The company	PDF not statedXBRL
2019	01/01/2019 – 31/12/2019	08/04/2020	The company	PDF XBRL
2018	01/01/2018 – 31/12/2018	29/04/2019	The company	PDF XBRL
2017	01/01/2017 – 31/12/2017	20/04/2018	The company	PDF XBRL
2016	01/01/2016 – 31/12/2016	11/04/2017	The company	PDF XBRL
2015	01/01/2015 – 31/12/2015	26/04/2016	The company	PDF XBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR

Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 9.2bnNo. 2 of 421

Better than 100% of the companies in the industry

EquityDKK 14.8bnNo. 2 of 431

Better than 100% of the companies in the industry

Number of employees569No. 5 of 431

Better than 99% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form

Rank among similar companies
Group	Gross profit	Equity
Companies with 500–999 employees207 companies in the comparison	No. 2of 189 Better than 99%	No. 4of 207 Better than 99%
Companies that are between 15 and 29 years old24,910 companies in the comparison	No. 8of 24,791 Better than 100%	No. 15of 24,909 Better than 100%
All companies of type A/S18,025 companies in the comparison	No. 19of 17,786 Better than 100%	No. 42of 18,024 Better than 100%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering

Gross profit

Zealand Pharma A/SDKK 9.2bn
Carlsberg A/SDKK 40.2bn
Gubra A/SDKK 2.6bn

Net profit

Zealand Pharma A/SDKK 6.5bn
Carlsberg A/SDKK 7bn
Gubra A/SDKK 1.7bn

Equity

Zealand Pharma A/SDKK 14.8bn
Carlsberg A/SDKK 30.7bn
Gubra A/SDKK 1.1bn

Employees

Zealand Pharma A/S569
Carlsberg A/S107
Gubra A/S311

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register

Owners

Polar Capital LLP5%
Avoro Life Sciences Fund LLC5% · 0% votes
Van Herk Investments B.V.5% · 0% votes
Zealand Pharma A/S5%

Zealand Pharma A/S

Subsidiaries and ownership shares

Zealand Pharma A/S5%

Subsidiaries are shown only if they are in the database.

Management

17 active registrations

Executive management

Executive management at Zealand Pharma A/S
Name	Role	Appointed
Adam Sinding Steensberg	CEO	30/03/2022
Henriette Wennicke	Director	01/11/2022

Board of directors

Board of directors at Zealand Pharma A/S
Name	Role	Appointed
Alf Gunnar Martin Nicklasson	Chair of the board	21/04/2015
Kirsten Aarup Drejer	Deputy chair	04/04/2019
Leonard Kruimer	Board member	04/04/2019
Anneline Nansen	Board member	01/09/2021
Ludovic Tranholm Otterbein	Board member	20/03/2024
Nikolaj Frederik Beck	Board member	20/03/2024
Enrique Alfredo Conterno Martinelli	Board member	20/03/2024
Elaine Sullivan	Board member	20/03/2024
Adam Krisko Nygaard	Board member	20/03/2024
Tanja Lund Erichsen	Deputy board member	20/03/2024
Katja Haaber Løje Hansen	Deputy board member	20/03/2024
Lars Elmelund Pedersen	Deputy board member	20/03/2024
Cecilie Kold	Deputy board member	20/03/2024
Iris Katharina Löw-Friedrich	Board member	26/03/2026
Camilla Sylvest	Board member	26/05/2026

Auditor: Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab
Founders: VX 10.312 ApS

Former management (70)

Former management at Zealand Pharma A/S
Name	Role	Appointed	Resigned
Per Emil Hasselbalch Stakemann	Director	01/04/1997	22/08/1997
Dan Buxbom	Chair of the board	06/01/1998	19/10/1998
Niels Erik Nielsen	Board member	22/12/1998	04/06/2003
Jørgen Buus Lassen	Chair of the board	22/12/1998	21/05/2003
Leif Helth Jensen	Board member	22/12/1998	19/12/2002
Leslie Lars Iversen	Board member	29/06/2000	12/11/2001
Michael Thomas Sember	Board member	21/08/2000	07/05/2002
Gudmund Tyge Korsgaard	Board member	21/05/2003	15/06/2007
Bo Lennart Bruce	Board member	21/05/2003	19/04/2007
Patrick John Paul Coleman	Board member	21/05/2003	26/05/2005
Bent Benny Andersen	Board member	21/05/2003	17/02/2005
Tom Larsen	Board member	21/05/2003	11/05/2004
Lone Skjøttgaard Due	Board member	11/05/2004	26/05/2008
Ketil Jørgen Haugan	Board member	11/05/2004	31/12/2005
Jan Honoré	Chair of the board	11/05/2004	18/02/2007
Thierry Claude Laugel	Board member	17/02/2005	22/02/2006
Lars Kolind	Deputy chair	26/05/2005	19/04/2007
Dr Alain Munoz	Board member	26/05/2005	22/02/2006
Eva Steiness	CEO	26/05/2005	30/11/2007
Christian Thorkildsen	Board member	01/01/2006	18/04/2016
Jean Christophe Renondin	Board member	22/02/2006	30/11/2009
Rémi Droller	Board member	22/02/2006	15/06/2007
Marlene Nørgaard Carolus	Board member	30/06/2006	29/04/2008
Jørgen Søberg Petersen	Director	01/09/2006	30/04/2008
Jesper Zeuthen	Chair of the board	19/04/2007	07/12/2007
Alain Munoz	Board member	15/06/2007	20/03/2024
Linda Sjøstrøm	Board member	21/12/2007	07/04/2009
Jens William Kindtler	Board member	21/12/2007	03/10/2008
Christian Herskind Jørgensen	Board member	29/04/2008	28/04/2011
Helle Størum	Board member	26/05/2008	18/04/2016
David Horn Solomon	CEO	04/09/2008	15/01/2015
Mogens Ibenfeldt	Director	04/09/2008	07/04/2010
Thomas Tscherning	Board member	03/10/2008	21/01/2010
Anders Vadsholt	Board member	30/04/2009	31/01/2010
Christian Grøndahl	Director	07/04/2010	15/03/2013
John Hyttel	Director	07/04/2010	30/01/2013
Mats Blom	Director	07/04/2010	28/03/2019
Florian Nicolas Christian Reinaud	Board member	28/04/2010	02/02/2015
Jutta Grevinde af Rosenborg	Board member	28/04/2011	29/04/2014
James Peter Arthur Benson	Board member	28/04/2011	02/06/2016
Michael John Owen	Board member	25/04/2012	20/03/2024
Daniël Jan Ellens	Chair of the board	30/04/2013	21/04/2015
Jørgen Lindegaard	Deputy chair	30/04/2013	21/04/2015
Hanne Heidenheim Bak	Deputy board member	29/04/2014	18/04/2016
Søren Vitfell Keller	Deputy board member	29/04/2014	31/12/2014
Jens Peter Stenvang	Board member	29/04/2014	20/03/2024
Maria Juul Kolding	Deputy board member	29/04/2014	31/12/2014
Britt Meelby Jensen	CEO	15/01/2015	28/02/2019
Catherine Moukheibir	Board member	21/04/2015	04/04/2019
Rosemary Crane	Board member	21/04/2015	04/04/2019
Anneline Nansen	Deputy board member	14/04/2016	31/08/2021
Anne Kragh Sager	Deputy board member	14/04/2016	10/04/2018
Christian Thorkildsen	Deputy board member	19/04/2016	02/04/2020
Hanne Heidenheim Bak	Board member	19/04/2016	02/04/2020
Helle Haxgart	Deputy board member	19/04/2016	30/11/2017
Helle Størum	Deputy board member	19/04/2016	31/08/2017
Rasmus Just	Board member	19/04/2016	01/12/2017
Helle Haxgart	Board member	01/12/2017	10/04/2018
Kirsten Aarup Drejer	Board member	19/04/2018	03/04/2019
Adam Sinding Steensberg	CEO	28/02/2019	21/04/2019
Jeffrey Berkowitz	Board member	04/04/2019	26/03/2026
Bernadette Mary Connaughton	Board member	04/04/2019	26/03/2026
Adam Sinding Steensberg	Director	22/04/2019	29/03/2022
Emmanuel Dulac	CEO	22/04/2019	22/04/2019
Emmanuel Dulac	CEO	22/04/2019	30/03/2022
Matthew Donald Dallas	Director	25/10/2019	31/08/2022
Gertrud Koefoed Rasmussen	Board member	02/04/2020	01/09/2021
Jacob Ulrik Fog	Deputy board member	02/04/2020	20/03/2024
Nikolaj Frederik Beck	Board member	02/04/2020	19/03/2024
Iben Louise Gjelstrup	Board member	02/04/2020	20/03/2024

Signing rule: Selskabet tegnes af bestyrelsens formand i forening med den administrerende direktør, eller af bestyrelsens formand i forening med et bestyrelsesmedlem, eller af en direktør i forening med 2 bestyrelsesmedlemmer, eller af den administrerende direktør i forening med en direktør eller af den samlede bestyrelse.

Address and production units

2 active production units

Sydmarken 11
2860 Søborg

Gladsaxe Municipality · Postcode 2860

Open in OpenStreetMap

Production units
Production unit	Address	Industry	Employees	P number
Zealand Pharma A/S - KH7	Knud Højgaards Vej 7, 2860 Søborg	Research and experimental development on natural sciences and engineering	289	1031565762
ZEALAND PHARMA A/S	Sydmarken 11, 2860 Søborg	Research and experimental development on natural sciences and engineering	276	1004228666

Purpose

Selskabets formål er at drive forskning, produktion, handel og dermed beslægtet virksomhed, primært indenfor medicinalbranchen.

The purpose is quoted from the register in Danish.

Changes year by year

271 registered events

262015

252016

152017

72018

292019

212020

132021

172022

122023

282024

62025

92026

20269 changescapital 3 · ownership 1 · management 4 · accounts 1

10/09CapitalShare capital changed from 71,578,758 DKK to 71,610,005 DKK
21/08OwnershipZEALAND PHARMA A/S registered as owner (5%)
08/06CapitalShare capital changed from 71,525,575 DKK to 71,578,758 DKK
26/05ManagementCamilla Sylvest appointed board member
27/03AccountsAnnual report for 2025 published
26/03ManagementIris Katharina Löw-Friedrich appointed board member
26/03ManagementJeffrey Berkowitz stepped down as board member
26/03ManagementBernadette Mary Connaughton stepped down as board member
19/03CapitalShare capital changed from 71,515,045 DKK to 71,525,575 DKK

20256 changescapital 4 · accounts 1 · industry 1

11/12CapitalShare capital changed from 71,364,728 DKK to 71,515,045 DKK
11/09CapitalShare capital changed from 71,343,804 DKK to 71,364,728 DKK
06/06CapitalShare capital changed from 71,051,296 DKK to 71,343,804 DKK
04/04AccountsAnnual report for 2024 published
20/03CapitalShare capital changed from 71,023,871 DKK to 71,051,296 DKK
01/01IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)

202428 changescapital 7 · accounts 1 · management 14 · ownership 6

12/09CapitalShare capital changed from 71,013,761 DKK to 71,023,871 DKK
22/08CapitalShare capital changed from 71,000,761 DKK to 71,013,761 DKK
26/06CapitalShare capital changed from 62,650,761 DKK to 71,000,761 DKK
13/06CapitalShare capital changed from 62,648,011 DKK to 62,650,761 DKK
26/03CapitalShare capital changed from 62,615,203 DKK to 62,648,011 DKK
21/03AccountsAnnual report for 2023 published
20/03ManagementLars Elmelund Pedersen appointed deputy board member
20/03ManagementKatja Haaber Løje Hansen appointed deputy board member
20/03ManagementTanja Lund Erichsen appointed deputy board member
20/03ManagementAdam Krisko Nygaard appointed board member
20/03ManagementElaine Sullivan appointed board member
20/03ManagementEnrique Alfredo Conterno Martinelli appointed board member
20/03ManagementNikolaj Frederik Beck appointed board member
20/03ManagementLudovic Tranholm Otterbein appointed board member
20/03ManagementCecilie Kold appointed deputy board member
20/03ManagementIben Louise Gjelstrup stepped down as board member
20/03ManagementJacob Ulrik Fog stepped down as deputy board member
20/03ManagementJens Peter Stenvang stepped down as board member
20/03ManagementMichael John Owen stepped down as board member
19/03ManagementNikolaj Frederik Beck stepped down as board member
05/03CapitalShare capital changed from 62,512,622 DKK to 62,615,203 DKK
25/01OwnershipVan Herk Investments B.V. registered as owner (5%)
25/01OwnershipVan Herk Management Services B.V. registered as owner (0%)
24/01OwnershipVan Herk Management Services B.V. is no longer registered as owner
24/01OwnershipVan Herk Investments B.V. is no longer registered as owner
08/01CapitalShare capital changed from 58,751,152 DKK to 62,512,622 DKK
08/01OwnershipAvoro Capital Advisors LLC registered as owner (0%)
08/01OwnershipAvoro Life Sciences Fund LLC registered as owner (5%)

202312 changescapital 9 · ownership 2 · accounts 1

07/12CapitalShare capital changed from 58,704,075 DKK to 58,751,152 DKK
16/11CapitalShare capital changed from 58,677,438 DKK to 58,704,075 DKK
19/10OwnershipPolar Capital LLP registered as owner (5%)
18/10OwnershipPolar Capital LLP is no longer registered as owner
14/09CapitalShare capital changed from 58,657,336 DKK to 58,677,438 DKK
24/08CapitalShare capital changed from 58,641,502 DKK to 58,657,336 DKK
08/06CapitalShare capital changed from 58,605,496 DKK to 58,641,502 DKK
23/05CapitalShare capital changed from 58,582,005 DKK to 58,605,496 DKK
03/04AccountsAnnual report for 2022 published
30/03CapitalShare capital changed from 52,003,057 DKK to 58,582,005 DKK
28/03CapitalShare capital changed from 51,968,463 DKK to 52,003,057 DKK
09/03CapitalShare capital changed from 51,702,098 DKK to 51,968,463 DKK

202217 changescapital 6 · management 5 · ownership 5 · accounts 1

08/12CapitalShare capital changed from 51,637,179 DKK to 51,702,098 DKK
17/11CapitalShare capital changed from 51,513,186 DKK to 51,637,179 DKK
01/11ManagementHenriette Wennicke appointed director
10/10OwnershipPolar Capital LLP registered as owner (10%)
07/10OwnershipVan Herk Management Services B.V. registered as owner (0%)
07/10OwnershipVan Herk Investments B.V. registered as owner (10%)
06/10OwnershipVan Herk Investments B.V. is no longer registered as owner
06/10OwnershipVan Herk Management Services B.V. is no longer registered as owner
04/10CapitalShare capital changed from 46,538,186 DKK to 51,513,186 DKK
08/09CapitalShare capital changed from 46,530,384 DKK to 46,538,186 DKK
31/08ManagementMatthew Donald Dallas stepped down as director
18/08CapitalShare capital changed from 46,526,510 DKK to 46,530,384 DKK
01/06CapitalShare capital changed from 43,634,142 DKK to 46,526,510 DKK
04/05AccountsAnnual report for 2021 published
30/03ManagementAdam Sinding Steensberg appointed ceo
30/03ManagementEmmanuel Dulac stepped down as ceo
29/03ManagementAdam Sinding Steensberg stepped down as director

202113 changescapital 9 · management 3 · accounts 1

10/12CapitalShare capital changed from 43,628,742 DKK to 43,634,142 DKK
19/11CapitalShare capital changed from 43,581,697 DKK to 43,628,742 DKK
10/09CapitalShare capital changed from 43,550,949 DKK to 43,581,697 DKK
01/09ManagementAnneline Nansen appointed board member
01/09ManagementGertrud Koefoed Rasmussen stepped down as board member
31/08ManagementAnneline Nansen stepped down as deputy board member
20/08CapitalShare capital changed from 43,541,838 DKK to 43,550,949 DKK
10/06CapitalShare capital changed from 43,451,842 DKK to 43,541,838 DKK
20/05CapitalShare capital changed from 43,449,842 DKK to 43,451,842 DKK
21/04AccountsAnnual report for 2020 published
09/04CapitalShare capital changed from 43,428,192 DKK to 43,449,842 DKK
19/03CapitalShare capital changed from 43,400,547 DKK to 43,428,192 DKK
27/01CapitalShare capital changed from 39,799,706 DKK to 43,400,547 DKK

202021 changescapital 10 · ownership 4 · accounts 1 · management 6

11/12CapitalShare capital changed from 39,794,956 DKK to 39,799,706 DKK
20/11CapitalShare capital changed from 39,778,961 DKK to 39,794,956 DKK
11/09CapitalShare capital changed from 39,765,110 DKK to 39,778,961 DKK
21/08CapitalShare capital changed from 39,734,151 DKK to 39,765,110 DKK
22/06OwnershipSUNSTONE LIFE SCIENCE VENTURES FUND I K/S is no longer registered as owner
18/06CapitalShare capital changed from 37,049,690 DKK to 39,734,151 DKK
12/06CapitalShare capital changed from 37,008,195 DKK to 37,049,690 DKK
26/05CapitalShare capital changed from 36,917,324 DKK to 37,008,195 DKK
15/04CapitalShare capital changed from 36,887,952 DKK to 36,917,324 DKK
08/04AccountsAnnual report for 2019 published
02/04ManagementGertrud Koefoed Rasmussen appointed board member
02/04ManagementIben Louise Gjelstrup appointed board member
02/04ManagementNikolaj Frederik Beck appointed board member
02/04ManagementJacob Ulrik Fog appointed deputy board member
02/04ManagementChristian Thorkildsen stepped down as deputy board member
02/04ManagementHanne Heidenheim Bak stepped down as board member
01/04OwnershipWellington Management Group LLP is no longer registered as owner
26/03CapitalShare capital changed from 36,146,136 DKK to 36,887,952 DKK
20/03CapitalShare capital changed from 36,054,661 DKK to 36,146,136 DKK
31/01OwnershipWellington Management Group LLP registered as owner (5%)
30/01OwnershipWellington Management Group LLP is no longer registered as owner

201929 changescapital 10 · management 15 · ownership 2 · address 1 · accounts 1

13/12CapitalShare capital changed from 36,023,686 DKK to 36,054,661 DKK
22/11CapitalShare capital changed from 35,865,461 DKK to 36,023,686 DKK
25/10ManagementMatthew Donald Dallas appointed director
13/09CapitalShare capital changed from 35,806,290 DKK to 35,865,461 DKK
05/09CapitalShare capital changed from 31,831,290 DKK to 35,806,290 DKK
05/09OwnershipVan Herk Investments B.V. registered as owner (15%)
05/09OwnershipVan Herk Management Services B.V. registered as owner (0%)
02/09AddressMoved to Sydmarken 11, 2860 Søborg
23/08CapitalShare capital changed from 31,814,790 DKK to 31,831,290 DKK
14/06CapitalShare capital changed from 31,725,475 DKK to 31,814,790 DKK
28/05CapitalShare capital changed from 31,679,936 DKK to 31,725,475 DKK
29/04AccountsAnnual report for 2018 published
22/04ManagementEmmanuel Dulac appointed ceo
22/04ManagementEmmanuel Dulac stepped down as ceo
22/04ManagementAdam Sinding Steensberg appointed director
21/04ManagementAdam Sinding Steensberg stepped down as ceo
05/04CapitalShare capital changed from 31,661,686 DKK to 31,679,936 DKK
04/04ManagementJeffrey Berkowitz appointed board member
04/04ManagementLeonard Kruimer appointed board member
04/04ManagementKirsten Aarup Drejer appointed deputy chair
04/04ManagementBernadette Mary Connaughton appointed board member
04/04ManagementRosemary Crane stepped down as board member
04/04ManagementCatherine Moukheibir stepped down as board member
03/04ManagementKirsten Aarup Drejer stepped down as board member
28/03ManagementMats Blom stepped down as director
20/03CapitalShare capital changed from 30,858,827 DKK to 31,661,686 DKK
15/03CapitalShare capital changed from 30,786,827 DKK to 30,858,827 DKK
28/02ManagementAdam Sinding Steensberg appointed ceo
28/02ManagementBritt Meelby Jensen stepped down as ceo

20187 changescapital 2 · accounts 1 · management 3 · ownership 1

14/12CapitalShare capital changed from 30,758,827 DKK to 30,786,827 DKK
14/09CapitalShare capital changed from 30,751,327 DKK to 30,758,827 DKK
20/04AccountsAnnual report for 2017 published
19/04ManagementKirsten Aarup Drejer appointed board member
10/04ManagementHelle Haxgart stepped down as board member
10/04ManagementAnne Kragh Sager stepped down as deputy board member
09/01OwnershipLegg Mason, Inc. is no longer registered as owner

201715 changesownership 2 · management 4 · capital 8 · accounts 1

27/12OwnershipWellington Management Group LLP registered as owner (5%)
01/12ManagementHelle Haxgart appointed board member
01/12ManagementRasmus Just stepped down as board member
30/11ManagementHelle Haxgart stepped down as deputy board member
20/11CapitalShare capital changed from 30,748,827 DKK to 30,751,327 DKK
22/09CapitalShare capital changed from 30,720,152 DKK to 30,748,827 DKK
01/09CapitalShare capital changed from 30,718,652 DKK to 30,720,152 DKK
31/08ManagementHelle Størum stepped down as deputy board member
09/08CapitalShare capital changed from 26,187,402 DKK to 30,718,652 DKK
15/06CapitalShare capital changed from 26,178,865 DKK to 26,187,402 DKK
30/05CapitalShare capital changed from 26,173,865 DKK to 26,178,865 DKK
27/04OwnershipKAPITALFORENINGEN LD is no longer registered as owner
13/04CapitalShare capital changed from 26,151,865 DKK to 26,173,865 DKK
11/04AccountsAnnual report for 2016 published
23/03CapitalShare capital changed from 26,142,365 DKK to 26,151,865 DKK

201625 changescapital 10 · ownership 4 · management 10 · accounts 1

08/12CapitalShare capital changed from 26,128,366 DKK to 26,142,365 DKK
25/11CapitalShare capital changed from 26,070,453 DKK to 26,128,366 DKK
17/11CapitalShare capital changed from 26,062,253 DKK to 26,070,453 DKK
29/09CapitalShare capital changed from 24,587,032 DKK to 26,062,253 DKK
23/09CapitalShare capital changed from 24,541,575 DKK to 24,587,032 DKK
06/09CapitalShare capital changed from 24,534,175 DKK to 24,541,575 DKK
15/07OwnershipSUNSTONE LIFE SCIENCE VENTURES A/S is no longer registered as owner
14/07OwnershipK/S SUNSTONE BIOMEDICAL VENTURE ANNEX III is no longer registered as owner
16/06CapitalShare capital changed from 24,492,906 DKK to 24,534,175 DKK
02/06ManagementJames Peter Arthur Benson stepped down as board member
26/05CapitalShare capital changed from 24,449,835 DKK to 24,492,906 DKK
20/05OwnershipSUNSTONE LIFE SCIENCE VENTURES A/S registered as owner (0%)
19/05OwnershipSUNSTONE CAPITAL A/S is no longer registered as owner
26/04AccountsAnnual report for 2015 published
19/04ManagementChristian Thorkildsen appointed deputy board member
19/04ManagementHelle Haxgart appointed deputy board member
19/04ManagementHelle Størum appointed deputy board member
19/04ManagementHanne Heidenheim Bak appointed board member
19/04ManagementRasmus Just appointed board member
18/04ManagementHanne Heidenheim Bak stepped down as deputy board member
18/04ManagementHelle Størum stepped down as board member
14/04CapitalShare capital changed from 24,399,382 DKK to 24,449,835 DKK
14/04ManagementAnneline Nansen appointed deputy board member
14/04ManagementAnne Kragh Sager appointed deputy board member
30/03CapitalShare capital changed from 24,352,769 DKK to 24,399,382 DKK

201526 changescapital 9 · ownership 9 · management 8

04/12CapitalShare capital changed from 24,289,299 DKK to 24,352,769 DKK
13/11CapitalShare capital changed from 24,112,843 DKK to 24,289,299 DKK
04/11CapitalShare capital changed from 24,052,000 DKK to 24,112,843 DKK
26/09CapitalShare capital changed from 23,901,298 DKK to 24,052,000 DKK
08/09CapitalShare capital changed from 23,518,108 DKK to 23,901,298 DKK
07/09OwnershipCDC Enterprises Capital Investissement is no longer registered as owner
05/08OwnershipKAPITALFORENINGEN LD registered as owner (5%)
04/08OwnershipKAPITALFORENINGEN LD is no longer registered as owner
20/06CapitalShare capital changed from 23,471,587 DKK to 23,518,108 DKK
20/06OwnershipSUNSTONE CAPITAL A/S registered as owner (0%)
19/06OwnershipSUNSTONE CAPITAL A/S is no longer registered as owner
09/06OwnershipLegg Mason, Inc. registered as owner (0%)
02/06CapitalShare capital changed from 23,420,100 DKK to 23,471,587 DKK
21/04ManagementAlf Gunnar Martin Nicklasson appointed chair of the board
21/04ManagementRosemary Crane appointed board member
21/04ManagementCatherine Moukheibir appointed board member
21/04ManagementDaniël Jan Ellens stepped down as chair of the board
21/04ManagementJørgen Lindegaard stepped down as deputy chair
11/04CapitalShare capital changed from 23,313,880 DKK to 23,420,100 DKK
21/03CapitalShare capital changed from 23,193,047 DKK to 23,313,880 DKK
17/03OwnershipCDC Enterprises Capital Investissement registered as owner (5%)
16/03OwnershipCDC Enterprises Capital Investissement is no longer registered as owner
16/03OwnershipInnovation Capital is no longer registered as owner
02/02ManagementFlorian Nicolas Christian Reinaud stepped down as board member
15/01ManagementBritt Meelby Jensen appointed ceo
15/01ManagementDavid Horn Solomon stepped down as ceo

20147 changesmanagement 7

31/12ManagementMaria Juul Kolding stepped down as deputy board member
31/12ManagementSøren Vitfell Keller stepped down as deputy board member
29/04ManagementMaria Juul Kolding appointed deputy board member
29/04ManagementJens Peter Stenvang appointed board member
29/04ManagementHanne Heidenheim Bak appointed deputy board member
29/04ManagementSøren Vitfell Keller appointed deputy board member
29/04ManagementJutta Grevinde af Rosenborg stepped down as board member

20135 changesmerger 1 · management 4

01/05MergerMerger registered in CVR
30/04ManagementDaniël Jan Ellens appointed chair of the board
30/04ManagementJørgen Lindegaard appointed deputy chair
15/03ManagementChristian Grøndahl stepped down as director
30/01ManagementJohn Hyttel stepped down as director

20121 changemanagement 1

25/04ManagementMichael John Owen appointed board member

20115 changescapital 1 · ownership 1 · management 3

12/12CapitalShare capital changed from 22,870,523 DKK to 23,193,047 DKK
24/11OwnershipKAPITALFORENINGEN LD registered as owner (10%)
28/04ManagementJames Peter Arthur Benson appointed board member
28/04ManagementJutta Grevinde af Rosenborg appointed board member
28/04ManagementChristian Herskind Jørgensen stepped down as board member

201013 changescapital 2 · ownership 4 · management 7

09/12CapitalShare capital changed from 22,018,116 DKK to 22,870,523 DKK
23/11OwnershipSUNSTONE LIFE SCIENCE VENTURES FUND I K/S registered as owner (5%)
23/11OwnershipK/S SUNSTONE BIOMEDICAL VENTURE ANNEX III registered as owner (5%)
23/11OwnershipSUNSTONE CAPITAL A/S registered as owner (0%)
03/11CapitalShare capital changed from 17,682,069 DKK to 22,018,116 DKK
03/11OwnershipCDC Enterprises Capital Investissement registered as owner (5%)
28/04ManagementFlorian Nicolas Christian Reinaud appointed board member
07/04ManagementMats Blom appointed director
07/04ManagementJohn Hyttel appointed director
07/04ManagementChristian Grøndahl appointed director
07/04ManagementMogens Ibenfeldt stepped down as director
31/01ManagementAnders Vadsholt stepped down as board member
21/01ManagementThomas Tscherning stepped down as board member

20091 changemanagement 1

30/04ManagementAnders Vadsholt appointed board member

20088 changesmanagement 6 · address 1 · industry 1

03/10ManagementThomas Tscherning appointed board member
03/10ManagementJens William Kindtler stepped down as board member
04/09ManagementDavid Horn Solomon appointed ceo
04/09ManagementMogens Ibenfeldt appointed director
26/05ManagementHelle Størum appointed board member
30/04AddressMoved to Smedeland 36, 2600 Glostrup
29/04ManagementChristian Herskind Jørgensen appointed board member
01/01IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)

20071 changemanagement 1

21/12ManagementJens William Kindtler appointed board member

20061 changecapital 1

30/06CapitalShare capital changed from 12,001,872 DKK to 17,682,069 DKK

20056 changescapital 4 · ownership 2

15/11CapitalShare capital changed from 10,866,167 DKK to 12,001,872 DKK
01/09CapitalShare capital changed from 7,206,635 DKK to 10,866,167 DKK
18/02OwnershipInnovation Capital registered as owner (0%)
18/02OwnershipInnovation Capital registered as owner (10%)
17/02CapitalShare capital changed from 5,401,081 DKK to 7,206,635 DKK
07/01CapitalShare capital changed from 2,633,492 DKK to 5,401,081 DKK

20031 changecapital 1

11/02CapitalShare capital changed from 1,496,787 DKK to 2,633,492 DKK

20021 changename 1

07/05NameName changed from ZEALAND PHARMACEUTICALS A/S to ZEALAND PHARMA A/S

20004 changescapital 4

02/11CapitalShare capital changed from 1,045,000 DKK to 1,496,787 DKK
04/10CapitalShare capital changed from 1,075,440 DKK to 1,045,000 DKK
18/09CapitalShare capital changed from 1,527,227 DKK to 1,075,440 DKK
24/07CapitalShare capital changed from 1,075,440 DKK to 1,527,227 DKK

19991 changecapital 1

15/12CapitalShare capital changed from 818,298 DKK to 1,075,440 DKK

19986 changescapital 5 · name 1

22/12CapitalShare capital changed from 409,149 DKK to 818,298 DKK
25/11CapitalShare capital changed from 356,647 DKK to 409,149 DKK
10/11CapitalShare capital changed from 275,697 DKK to 356,647 DKK
20/10NameName changed from PEPTIDE PROBE TECHNOLOGIES ApS to ZEALAND PHARMACEUTICALS A/S
19/10CapitalShare capital changed from 135,200 DKK to 275,697 DKK
06/01CapitalShare capital changed from 125,000 DKK to 135,200 DKK

19972 changesname 1 · founded 1

23/08NameName changed from ApS KBUS 8 NR. 4581 to PEPTIDE PROBE TECHNOLOGIES ApS
01/04FoundedRegistered as ApS KBUS 8 NR. 4581

Related companies

Same industry in Gladsaxe

Fortrea Denmark ApS31 employees
Fida Biosystems ApS23 employees
Kvasir Technologies ApS21 employees
Nbcd A/S21 employees
Chromologics ApS19 employees
Cellugy ApS18 employees

See all →

Same people in management

Novo Nordisk A/Svia Britt Meelby Jensen
Danish Crown A/Svia Camilla Sylvest
ISS Facility Services A/Svia Per Emil Hasselbalch Stakemann
Falck Danmark A/Svia Per Emil Hasselbalch Stakemann
Tryg Forsikring A/Svia Per Emil Hasselbalch Stakemann
Bravida Danmark A/Svia Niels Erik Nielsen

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVR Report a correction